Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Nasdaq Real Time Price USD

Aimei Health Technology Co., Ltd (AFJK)

Compare
11.00
+0.01
+(0.09%)
At close: April 3 at 4:00:00 PM EDT
Loading Chart for AFJK
  • Previous Close 10.99
  • Open 11.00
  • Bid --
  • Ask --
  • Day's Range 11.00 - 11.00
  • 52 Week Range 10.24 - 11.01
  • Volume 46,024
  • Avg. Volume 10,213
  • Market Cap (intraday) 67.339M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 39.29
  • EPS (TTM) 0.28
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AFJK

View More

Performance Overview: AFJK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AFJK
2.80%
S&P 500 (^GSPC)
8.25%

1-Year Return

AFJK
6.80%
S&P 500 (^GSPC)
3.55%

3-Year Return

AFJK
8.27%
S&P 500 (^GSPC)
18.71%

5-Year Return

AFJK
8.27%
S&P 500 (^GSPC)
116.85%

Compare To: AFJK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AFJK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    67.34M

  • Enterprise Value

    67.54M

  • Trailing P/E

    39.29

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.93

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -0.92%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    2.55M

  • Diluted EPS (ttm)

    0.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.21k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -103.21k

Research Analysis: AFJK

View More

Company Insights: AFJK

Research Reports: AFJK

View More

People Also Watch